carbostyril has been researched along with Retinal Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jiang, N; Li, Y; Li, Z; Su, W; Wan, P; Yu, Z; Zhang, Y; Zhu, Y; Zhuo, Y | 1 |
Audo, I; Faure, C; Letessier, JB; Robert, MP; Zeitz, C | 1 |
Hirano, K; Kato, K; Kondo, M; Matsubara, H; Matsunaga, K; Sugimoto, M; Takashima, Y | 1 |
1 trial(s) available for carbostyril and Retinal Diseases
Article | Year |
---|---|
Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy.
Topics: Aged; Alanine; Cell Count; Conjunctiva; Female; Goblet Cells; Humans; Male; Middle Aged; Quinolones; Retinal Diseases; Time Factors; Treatment Outcome; Vitrectomy | 2016 |
2 other study(ies) available for carbostyril and Retinal Diseases
Article | Year |
---|---|
Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Cytokines; Inflammation; Male; Mice; Mice, Inbred C57BL; Quinolones; Reperfusion Injury; Retina; Retinal Diseases; Retinal Neurons; Retinal Vessels | 2020 |
Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.
Topics: Antipsychotic Agents; Aripiprazole; Coloring Agents; Dark Adaptation; Electrooculography; Electroretinography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Piperazines; Quinolones; Retina; Retinal Diseases; Retinal Pigment Epithelium; Schizophrenia; Tomography, Optical Coherence; Visual Acuity | 2015 |